• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Medherant touts results for ibuprofen transdermal patch

November 5, 2018 By Sarah Faulkner

Medherant logo - updatedMedherant said today that it successfully finished two Phase I studies with its ibuprofen transdermal drug-delivery patch.

According to the UK-based company, the Tepi patch was well tolerated by the participants of a skin irritation study.

The company also touted results from a second study, which compared blood concentrations of ibuprofen following repeated application of the Tepi patch versus a single oral dose of ibuprofen. Medherant reported that blood levels of ibuprofen were significantly lower following application of the patch, indicating that the patch was successful as a means of localized drug delivery.

Medherant also noted that it is looking for financial support in a Series A round to support a Phase III study of the ibuprofen patch.

“These positive Phase I results signify a major milestone in the ongoing development of our Tepi Patch drug delivery technology and demonstrate that our novel adhesive can be used safely,” CEO Nigel Davis said in prepared remarks. “The successful completion of these trials is a testament to our team’s hard work and dedication. We look forward to taking the Ibuprofen Tepi Patch into Phase III clinical testing.”

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Clinical Trials, Drug-Device Combinations, Featured, Neurological, Pharmaceuticals Tagged With: medherant

IN CASE YOU MISSED IT

  • Medtronic to invest $50M in India Diabetes center
  • Flat Medical partners with Mercury Medical on smart syringe distribution
  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS